These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4856788)

  • 1. Inhibition of normal clotting and Fletcher factor activity by rabbit anti-kallikrein antiserum.
    Saito H; Ratnoff OD
    Nature; 1974 Apr; 248(449):597-8. PubMed ID: 4856788
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
    Soulier JP; Gozin D
    Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fletcher factor deficiency and myocardial infarction.
    Currimbhoy Z; Vinciguerra V; Palakavongs P; Kuslansky P; Degnan TJ
    Am J Clin Pathol; 1976 Jun; 65(6):970-4. PubMed ID: 937251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A method of obtaining rabbit precipitating sera with high titer of antibodies to kallikrein and trypsin].
    Protsenko VA; Spitsyn IF; Karpitskii VV
    Lab Delo; 1972; 7():438-9. PubMed ID: 4124735
    [No Abstract]   [Full Text] [Related]  

  • 7. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease.
    Saito H; Poon MC; Vicic W; Goldsmith GH; Menitove JE
    J Lab Clin Med; 1978 Jul; 92(1):84-95. PubMed ID: 659966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current views on the relationship of the kallikrein-kinin system to coagulation and fibrinolysis].
    Poucková P
    Cesk Fysiol; 1977; 26(6):549-54. PubMed ID: 342127
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of precipitating antibodies to pancreatic kallikrein on arginine esterase contact activation in human and rabbit blood].
    Karpitskiĭ VV; Guz SIa
    Vopr Med Khim; 1979; 25(3):242-5. PubMed ID: 452486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening coagulation tests and clotting factors in homozygous beta-thalassemia.
    Caocci L; Alberti M; Burrai P; Corda R
    Acta Haematol; 1978; 60(6):358-64. PubMed ID: 103356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prekallikrein deficiency in man.
    Wuepper KD
    J Exp Med; 1973 Dec; 138(6):1345-55. PubMed ID: 4762550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallikrein inhibition and C1-esterase inhibitor levels in patients with the lupus inhibitor.
    Killeen AA; Meyer KC; Vogt JM; Edson JR
    Am J Clin Pathol; 1987 Aug; 88(2):223-8. PubMed ID: 3113230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of suramin on complement, blood clotting, fibrinolysis and kinin formation.
    Eisen V; Loveday C
    Br J Pharmacol; 1973 Dec; 49(4):678-87. PubMed ID: 4788038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fletcher factor deficiency (Report of a new case).
    Colla G; Carrea M; Sbaffi A
    Ric Clin Lab; 1983; 13(4):443-8. PubMed ID: 6558774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kallikrein-kinin system and coagulation homeostasis in the disseminated intravascular coagulation syndrome].
    Kachorovskiĭ BV; Vygovskaia IaI; Vorobel' AV; Buzherak NF
    Probl Gematol Pereliv Krovi; 1979 Jul; 24(7):23-8. PubMed ID: 471979
    [No Abstract]   [Full Text] [Related]  

  • 17. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.
    Holmer E; Kurachi K; Söderström G
    Biochem J; 1981 Feb; 193(2):395-400. PubMed ID: 6914196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parameters of the kallikrein-kinin, coagulation and fibrinolytic systems as early indicators of kidney transplant rejection.
    Schrader J; Gallimore MJ; Eisenhauer T; Isemer FE; Schoel G; Warneke G; Brüggemann M; Scheler F
    Nephron; 1988; 48(3):183-9. PubMed ID: 3281044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [General mechanisms of biochemical regulation of the kallikrein, clotting and fibrinolytic systems of the blood].
    Gomazkov OA; Komissarova NV
    Usp Sovrem Biol; 1976; 82(6):356-70. PubMed ID: 65846
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of trypsin inhibitor of a peptide-protein nature on kallikreins from human and rabbit blood stream].
    Paskhina TS; Krinskaia AV; Zykova VP
    Biokhimiia; 1975; 40(2):302-9. PubMed ID: 1081887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.